Richard Donovick
About
In The Last Decade
Richard Donovick
23 papers receiving 320 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 102
- Pharmacology 91
- Epidemiology 82
- Infectious Diseases 80
- Organic Chemistry 65
Countries citing papers authored by Richard Donovick
This map shows the geographic impact of Richard Donovick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Donovick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Donovick more than expected).
Fields of papers citing papers by Richard Donovick
This network shows the impact of papers produced by Richard Donovick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Donovick. The network helps show where Richard Donovick may publish in the future.
Co-authorship network of co-authors of Richard Donovick
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Donovick. A scholar is included among the top collaborators of Richard Donovick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Donovick. Richard Donovick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | On the Action of Thiosemicarbazones in Experimental Tuberculosis in the Mouse | 0 |
| 2 | 3 | |
| 3 | Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. | 65 |
| 4 | Thiostrepton, a new antibiotic. I. In vitro studies. | 36 |
| 5 | 73 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 2 | |
| 11 | Hamycin: in vitro and in vivo studies. | 5 |
| 12 | Hamycin: in vitro and in vivo studies. | 11 |
| 13 | 1 | |
| 14 | 6 | |
| 15 | 2 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | In vitro studies on isonicotinic acid hydrazide. | 25 |
| 19 | Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones. | 42 |
| 20 | 39 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.